PGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma, and hospitals. Anandha Padmanabhan shares insights on navigating hospital capacity expansions, China-plus-one opportunities, GLP-1 dynamics, and key stock-selection strategies across healthcare sub-sectors.
PGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma, and hospitals. Anandha Padmanabhan shares insights on navigating hospital capacity expansions, China-plus-one opportunities, GLP-1 dynamics, and key stock-selection strategies across healthcare sub-sectors.
<iframe src="https://hindustansphere.com/embed/cluster/aa72eeca9dcbc956d291d7fd52a96a9aabd92912" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alpha"></iframe>
